Filing Details

Accession Number:
0001144204-18-033791
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-11 17:37:56
Reporting Period:
2018-06-08
Accepted Time:
2018-06-11 17:37:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1644963 Avenue Therapeutics Inc. ATXI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
941841 Md A Lindsay Rosenwald C/O Avenue Therapeutics, Inc.
2 Gansevoort Street, 9Th Floor
New York NY 10014
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-08 5,234 $4.34 25,234 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Weighted average price. These shares were purchased in multiple transactions ranging from $4.20 to $4.40. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.
  2. Includes 10,000 shares of restricted stock.